Dr. Bishoy M. Faltas
@FaltasLab
Followers
7K
Following
82K
Statuses
12K
Physician-Scientist. Chief Research Officer @EngIPM. Gellert-John P. Leonard Scholar, Associate Professor @WeillCornell. Husband & father. RTs ≠ endorsements
Manhattan, NY
Joined February 2015
RT @biorxiv_bioinfo: SAMCell: Generalized Label-Free Biological Cell Segmentation with Segment Anything #biorxiv_bi…
0
2
0
RT @SamuelBHume: Top 5 advances in medicine this week (🧵) 1. A vaccine to prevent recurrence of kidney cancer This is a small trial – 9 p…
0
136
0
RT @NatureBiotech: RNA structures are built from cryogenic electron microscopy maps using deep learning and backbone tracing
0
47
0
RT @srikosuri: It’s been a tough few weeks. My 10yo daughter was diagnosed with a very rare, aggressive cancer called interdigitating dendr…
0
5K
0
RT @Aiims1742: The NIH reduces its maximum indirect rate for research from 60% to 15% with immediate effect.
0
24
0
RT @james_y_zou: The shift from AI as tools to AI as agents has tremendous implications for medicine and healthcare. @EricTopol and I shar…
0
70
0
RT @Nature: Simulations and experiments suggest that an egg is best cooked by repeatedly alternating between boiling and tepid water https…
0
51
0
RT @SamuelBHume: "Our studies suggest that proteins have evolved to harbor at least two types of codes, one for folding and another for int…
0
74
0
RT @SamuelBHume: This is like AlphaFold, but for protein localisation rather than folding It's a deep learning model that predicts a prote…
0
333
0
RT @NatureBiotech: An AI-generated small-molecule inhibitor treats fibrosis in vivo and in phase I clinical trials
0
62
0
RT @ElizSMcKenna: Now online in @CD_AACR: High-Purity Circulating Tumor Cell RNA Sequencing Identifies #ProstateCancer Lineage Phenotypes P…
0
9
0
RT @christinemphmd: Applications are open now for #BMT and #CellularTherapy fellowship at @WeillCornell! @WeillCornellBMT @WCMHemOncFellow…
0
6
0
RT @SamuelBHume: This is such a striking figure (albeit not surprising): 5-year survival rates of different cancer types, when diagnosed at…
0
24
0
RT @tompowles1: Bladder cancer highlights #ASCOGU25 1) outcomes of pCR patients for gem/cis/durvalumab (NIAGARA) 2) neoadjuvant gem/cis/dur…
0
27
0
Congratulations @DrChoueiri and team! Super exciting work!
1/ JUST IN: an 8 year #kidneycancer journey now published in @Nature: “A personalized neoantigen vaccine generates anti-tumor immunity in high-risk renal cell carcinoma”. A trial of #RCC vaccine, led together with first author @BraunMDPhD @YaleCancer and #PatrickOtt #DerinKeskin #CatherineWu @DanaFarber
@DanaFarber_GU @OncoAlert @DFCI_NeoVax
0
1
10
Please join BCAN in congratulating the recipients of our 2024 Career Development Award, @anglayteng of @Stanford and @BrendanGuercio of @wilmotcancer. Both Drs. Ang and Guercio presented outstanding proposals that you can learn more about here:
2
6
34
RT @labs_mann: Interesting survey commented out in @Nature shows that researchers believe AI outperforms humans in 20+ research tasks. Seba…
0
14
0
RT @naxerova: Cancer evolution enthusiasts - you might be interested in some new data from our lab on quantifying cell divisions along evol…
0
71
0
RT @simocristea: Impressive advancement in Computational Pathology. A new multimodal foundation model by @AI4Pathology trained on 47,000 p…
0
101
0